Magnesium Sulfate: what to check before you give it

What it does and why it is prescribed

Magnesium sulfate is an anticonvulsant and a smooth muscle relaxant. In obstetrics it is the first-line drug for preventing and treating seizures in severe pre-eclampsia and eclampsia, and it is used off-label as a tocolytic to delay preterm labour for a short window, usually to allow corticosteroids to work. Outside obstetrics you will see it for torsades de pointes, severe asthma exacerbations unresponsive to first-line bronchodilators, and correction of hypomagnesemia.

The mechanism is central nervous system depression and blockade of neuromuscular transmission by competing with calcium at the presynaptic membrane. That same mechanism is why it stops seizures and why it can, at high enough serum levels, stop breathing. The therapeutic window is narrow, which is the reason this drug carries more monitoring requirements than most infusions on the unit.

Nursing considerations before giving it

Check baseline deep tendon reflexes, respiratory rate, blood pressure and urine output before starting the infusion, and confirm renal function. Magnesium is cleared almost entirely by the kidneys, so a patient with reduced renal function or oliguria (under 30 mL/hour) is at higher risk of accumulation and toxicity even at a standard dose.

Use an infusion pump for every magnesium sulfate order, loading dose and maintenance alike. Confirm the concentration against your facility's protocol and have a second nurse independently verify the pump settings, as this is a high-alert medication on most institutions' lists. Have calcium gluconate available at the bedside before you start the infusion, not after signs of toxicity appear.

Document a full neurological and respiratory baseline, since everything you monitor afterward is compared against it. If the patient is in labour, confirm continuous fetal monitoring is in place before the loading dose runs, as magnesium crosses the placenta and can affect fetal tone and heart rate variability.

What to monitor

Deep tendon reflexes are your earliest warning sign and should be checked at least hourly, typically the patellar reflex. A reflex that goes from brisk to diminished to absent is the first measurable change in magnesium toxicity, and it precedes respiratory depression in the great majority of cases. Grade and document the reflex every time you check it, not just as present or absent.

Respiratory rate must stay above 12 breaths per minute; below that, hold the infusion and reassess immediately. Monitor urine output hourly, since output under 30 mL/hour signals reduced clearance and rising risk of toxicity even if the infusion rate has not changed. Continuous pulse oximetry and cardiac monitoring are standard for the same reason.

Serum magnesium levels are drawn per protocol, usually four to six hours after the loading dose and then periodically through the infusion. Therapeutic range for seizure prophylaxis is typically 4 to 7 mEq/L; levels above 8 mEq/L are associated with loss of reflexes, and levels above 12 mEq/L with respiratory paralysis and cardiac arrest. Correlate the number with the clinical picture rather than treating the level in isolation.

Side effects versus adverse effects

Expected side effects at therapeutic doses include flushing, a feeling of warmth, headache, nausea, and a sensation of heaviness in the limbs. These are uncomfortable but not dangerous, and patients should be told to expect them so they do not panic when the infusion starts.

Adverse effects mark the drug moving from therapeutic to toxic, and they follow a predictable sequence: loss of deep tendon reflexes first, then respiratory depression, then cardiac conduction changes and, at the extreme, cardiac arrest. The distinction matters clinically. A flushed, warm patient who still has brisk reflexes and a normal respiratory rate needs reassurance. A patient with absent reflexes needs the infusion held and the provider notified, regardless of how they otherwise look.

What to hold for and when to call

Hold the infusion and notify the provider immediately for absent deep tendon reflexes, respiratory rate under 12 breaths per minute, oxygen saturation under 95%, urine output under 30 mL/hour over two consecutive hours, or any change in level of consciousness. Do not wait for a serum level to confirm what the bedside assessment is already telling you.

Have calcium gluconate drawn up and available before these signs appear, not fetched afterward. The standard adult dose is 1 g (10 mL of a 10% solution) given intravenously over several minutes, and it should reverse the neuromuscular and cardiac effects of magnesium within minutes. After calcium gluconate is given, continue to monitor reflexes, respiratory rate and cardiac rhythm closely, since a second dose may be needed if toxicity recurs.

Patient teaching

Tell the patient, before the infusion starts, that flushing, warmth and a heavy or weak feeling in the arms and legs are expected and will ease once the infusion is complete or the dose is adjusted. Reassure them this is different from an allergic reaction and does not mean something is wrong.

Ask the patient to report blurred vision, difficulty speaking, severe drowsiness or trouble breathing straight away, since these can be early signs that the level is climbing rather than expected effects. If the patient is being treated for pre-eclampsia, explain why frequent reflex checks, blood pressure readings and blood draws are happening so often; the monitoring is protecting them, not a sign that something has gone wrong.